(Nitro, BT, p-Nitrotetrazolium Blue; 2, 2´-Di-p-nitrophenyl-5, 5´diphenyl-[3, 3´-dimethoxy-4, 4´-diphenylene] ditetrazolium chloride)
C40H30Cl2N10O6 F.W. 817.6 CAS 298-83-9
Approx. 98% (TLC).
Contains up to 10% solvent. A substrate for dehydrogenases and other oxidases
Tablet contains 10mg substrate per tablet.